A business in context
ONC research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-28 | Wang Xiaodong | M · Exercise / conversion | American Depositary Shares | 31028.0 | 36.9 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 160.0 | 356.97 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 120.0 | 358.71 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 40.0 | 359.16 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 2241.0 | 361.05 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 738.0 | 367.23 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 3499.0 | 363.1 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 3419.0 | 364.07 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 2047.0 | 365.85 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 14525.0 | 366.58 |
| 2026-09-28 | Wang Xiaodong | S · Sale | American Depositary Shares | 4239.0 | 362.17 |
| 2026-09-28 | Wang Xiaodong | M · Exercise / conversion | Share Option (Right to Buy) | 403364.0 | 0.0 |
| 2026-09-14 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | M · Exercise / conversion | American Depositary Shares | 30768.0 | 36.83 |
| 2026-09-14 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | M · Exercise / conversion | American Depositary Shares | 30768.0 | 36.83 |
| 2026-09-14 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | M · Exercise / conversion | Non-Qualified Share Options | 30768.0 | 0.0 |
| 2026-09-14 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | M · Exercise / conversion | Non-Qualified Share Options | 30768.0 | 0.0 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 10688.0 | 349.28 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 7492.0 | 348.31 |
| 2026-09-08 | Wang Xiaodong | M · Exercise / conversion | American Depositary Shares | 31027.0 | 36.9 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 1181.0 | 345.38 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 6569.0 | 350.27 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 1721.0 | 348.01 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 1517.0 | 347.39 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 2841.0 | 346.16 |
| 2026-09-08 | Wang Xiaodong | S · Sale | American Depositary Shares | 6278.0 | 351.25 |
| 2026-09-08 | Wang Xiaodong | M · Exercise / conversion | Share Option (Right to Buy) | 403351.0 | 0.0 |
| 2026-09-01 | Ball Titus B. | S · Sale | American Depositary Shares | 132.0 | 355.86 |
| 2026-08-25 | Wu Xiaobin | S · Sale | American Depositary Shares | 280.0 | 380.0 |
| 2026-08-12 | OYLER JOHN | S · Sale | American Depositary Shares | 14102.0 | 359.12 |
| 2026-08-12 | OYLER JOHN | S · Sale | American Depositary Shares | 1980.0 | 354.71 |
| 2026-08-12 | OYLER JOHN | S · Sale | American Depositary Shares | 2515.0 | 356.43 |
| 2026-08-12 | OYLER JOHN | S · Sale | American Depositary Shares | 15396.0 | 357.63 |
| 2026-08-12 | OYLER JOHN | S · Sale | American Depositary Shares | 20899.0 | 358.41 |
| 2026-08-11 | Lee Chan Henry | S · Sale | American Depositary Shares | 2666.0 | 360.0 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | American Depositary Shares | 796.0 | 159.03 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | American Depositary Shares | 1058.0 | 213.32 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | American Depositary Shares | 812.0 | 194.47 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | Share Option (Right to Buy) | 10348.0 | 0.0 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | Share Option (Right to Buy) | 13754.0 | 0.0 |
| 2026-08-11 | Lee Chan Henry | M · Exercise / conversion | Share Option (Right to Buy) | 10556.0 | 0.0 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 13695.0 | 359.32 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 8081.0 | 360.33 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 14569.0 | 361.47 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 11568.0 | 362.34 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 13403.0 | 363.45 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 5211.0 | 364.31 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 3176.0 | 365.26 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 1200.0 | 366.31 |
| 2026-08-11 | OYLER JOHN | S · Sale | American Depositary Shares | 4.0 | 367.0 |
| 2026-08-10 | OYLER JOHN | S · Sale | American Depositary Shares | 67.0 | 350.0 |
Identity & relationships
SEC issuer · 0001651308BeOne Medicines Ltd.
Search names and former names
- BeiGene, Ltd. · former SEC name · 2015-08-28 to 2025-05-27
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $3.81B | $4.09B |
| 2023-12-31 | $2.46B | $2.72B |
| 2022-12-31 | $1.42B | $1.63B |
| 2021-12-31 | $1.18B | $1.46B |
| 2020-12-31 | $308.87M | $402.11M |
| 2019-12-31 | $428.21M | $564.32M |
| 2018-12-31 | $198.22M | $265.96M |
| 2017-12-31 | $238.39M | $327.68M |